National Mpox Webinar: Vaccination and Testing

Course Overview
There has been an increase of local mpox transmission rates in Australia, namely in NSW and VIC, but also in most jurisdictions. Although vaccination rates are rising, in NSW and VIC, only 15-20% have completed the full required course of two doses of the mpox vaccine (GBQ+ periodic survey). Testing is still imperative even in those who are vaccinated, as those who suffer milder disease may transmit it to someone without adequate protection, potentially leading to severe illness requiring hospitalisation. This webinar will discuss vaccination strategies, when to consider mpox as a differential diagnosis, and provide insights on clade 1b.

Target Audience
Doctors & Nurses in all healthcare settings

Speakers/Facilitators
Chair:
Dash Heath-Paynter, Health Equity Matters
Speakers:
Rose Foster, Department of Health and Ageing
Dr. Nick Medland, Kirby Institute
James Gray, Health Equity Matters
Dr. James McMahon, Alfred Hospital
Dr. Andrew Redmond, Royal Brisbane Women’s Hospital
Course Components
1.5 hour webinar

Learning Outcomes
Summarize Mpox transmission and vaccination rates across all Australian jurisdictions
Prepare healthcare practices for delivering Mpox vaccination to at-risk populations
Apply knowledge of Mpox signs and symptoms to effectively test at-risk individuals
Understand the distinctions between Mpox clades 1b and 2b
Endorsement & CPD
This is an RACGP-approved CPD activity under the RACGP CPD Program. It is accredited for 1.5 educational activity hours.

This activity has been approved by ACRRM as an accredited activity. Allocated 1.5 educational activity hours: .25 Performance Review hours and 1.25 Educational Activity hours.

HIV s100 Prescribers will receive 1 ASHM non-HIV CPD point for attending the session. Please note HIV prescribers can be awarded a maximum of 2 non-HIV CPD points per year to contribute towards their prescriber status.

For more information, contact ASHM at education@ashm.org.au or 0431320429.